AccessibilityHelp
Cambridge Nutritional Sciences Plc logo

Cambridge Nutritional Sciences Plc(LSE) CNSL

Market Cap£3.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-95%
5 Year-97%
1 Year-43%
1 Month+3%
£0.02
+6.67%
+0.00Today
Cambridge Nutritional Sciences Plc last closing stock price
MetricPriceDate
Last closeGBX 1.552026-10-23
Cambridge Nutritional Sciences Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-11.43%GBX 1.752026-10-16
1 month+3.33%GBX 1.502026-09-23
3 month-11.43%GBX 1.752026-07-24
Year to date-20.51%GBX 1.952025-12-31
1 year-42.59%GBX 2.702025-10-23
3 year-11.43%GBX 1.752023-10-24
5 year-96.99%GBX 51.502021-10-22
Since inception-95.48%GBX 0.342007-08-16

Cambridge Nutritional Sciences Plc Financials at a Glance

Market Cap

£3.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£15.31M

Net Income (TTM)

-£4.26M

EPS (TTM)

-£0.02

P/E Ratio

-0.63

Dividend

£0.00

Beta (Volatility)

0.19 (Low)

Price

£0.02

Volume

586,966

Open

£0.02

Previous Close

£0.02

Daily Range

£0.01 - £0.02

52-Week Range

£0.01 - £0.03

Estimated Earnings Date

Nov 19, 2026

CNSL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cambridge Nutritional Sciences Plc

Cambridge Nutritional Sciences plc, established in 1987 and headquartered in London, UK, specializes in the development and supply of medical diagnostic products. The company operates primarily in the food sensitivity testing market, offering innovative testing kits and clinical analysis services.

Products and Services
  • Foodprint branded kits for food sensitivity testing
  • Clinical analysis services for healthcare professionals
  • Food Detective consumer food test kits
Growth Outlook
  • Revenue increased to £3.11 million in the latest quarter
  • Gross profit margin remains strong at 60.67% in Q4 2025
  • Global market presence across multiple continents supports expansion potential
Financial Highlights
  • Trailing twelve months revenue of £12.5 million
  • Current ratio of 3.40 indicates strong liquidity
  • Net income of £370,000 in Q4 2024 shows profitability
Cambridge Nutritional Sciences plc is positioned in a growing sector, focusing on food sensitivity testing, which is increasingly relevant in today's health-conscious market. The company's diverse product offerings and strong gross profit margins indicate a solid foundation for future growth. Recent financial performance highlights, including a notable increase in revenue and a healthy current ratio, suggest that the company is well-equipped to navigate market challenges and capitalize on emerging opportunities. With a global reach and a commitment to innovation, Cambridge Nutritional Sciences plc presents an intriguing option for investors interested in the healthcare and diagnostics sector.
AI Generated • Oct 5, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

James Cooper

Website

www.omegadiagnostics.com

Headquarters

London, GL EC4M 7WS, GB

CNSL Financials

Key Financial Metrics (TTM)

Gross Margin

61.32%

Operating Margin

-15.01%

Net Income Margin

-83.53%

Return on Equity

-69.62%

Return on Capital

-18.00%

Return on Assets

-78.22%

Earnings Yield

-1.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£3.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

237.95M

Volume

586.97K

Avg. Volume

447.49K

Financials (TTM)

Gross Profit

£9.28M

Operating Income

-£1.72M

EBITDA

£1.81M

Operating Cash Flow

-£1.05M

Capital Expenditure

-£478.00K

Free Cash Flow

-£1.53M

Cash & ST Invst.

£2.64M

Total Debt

£125.00K

Cambridge Nutritional Sciences Plc Performance Analysis

Cambridge Nutritional Sciences Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31GBP 7,546,000-11.6%
20242024-03-31GBP 9,774,00029.5%
20252025-03-31GBP 8,330,000-14.8%
20262026-03-31GBP 6,975,000-16.3%
Cambridge Nutritional Sciences Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30N/A
Q42025-03-31N/A
Q22025-09-30N/A
Q42026-03-31N/A
Cambridge Nutritional Sciences Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31GBP -0.02-73.1%
20242024-03-31GBP -0.00-91.6%
20252025-03-31GBP 0.01N/A
20262026-03-31GBP -0.02N/A
Cambridge Nutritional Sciences Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30N/A
Q42025-03-31N/A
Q22025-09-30N/A
Q42026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£3.11M

-35.7%

Gross Profit

£1.89M

-31.0%

Gross Margin

60.67%

N/A

Market Cap

£3.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£43.39K

N/A

Employees

85

N/A

Net Income

-£5.43M

-1567.3%

EBITDA

-£325.00K

-213.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£2.64M

-51.6%

Total Debt

£125.00K

-15.5%

Accounts Receivable

£1.95M

+14.8%

Inventory

£655.00K

+7.9%

Long Term Debt

£25.00K

+0.0%

Short Term Debt

£100.00K

-18.7%

Return on Assets

-78.22%

N/A

Return on Invested Capital

-18.10%

N/A

Free Cash Flow

-£470.00K

-139.7%

Operating Cash Flow

-£400.00K

-132.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SUN.LSurgical Innovations Group plc
£0.00+0.00%
N4P.LN4 Pharma Plc
£0.00+0.00%
AGL.LCelLBxHealth plc
£0.01-5.64%
PRM.LProteome Sciences plc
£0.01-0.37%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About CNSL

What is the current price of Cambridge Nutritional Sciences Plc?

Cambridge Nutritional Sciences Plc is trading at £0.02 per share.

What is the 52-week range for Cambridge Nutritional Sciences Plc?

Over the past 52 weeks, Cambridge Nutritional Sciences Plc has traded between £0.01 and £0.03.

How much debt does Cambridge Nutritional Sciences Plc have?

As of the most recent reporting period, Cambridge Nutritional Sciences Plc reported total debt of £125.00K.

How much cash does Cambridge Nutritional Sciences Plc have on hand?

Cambridge Nutritional Sciences Plc reported £2.64M in cash and cash equivalents in its most recent financial results.

What is Cambridge Nutritional Sciences Plc’s dividend yield?

Cambridge Nutritional Sciences Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services